Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Labetuzumab Biosimilar - Research Grade

Product Specifications

Background

Uses the same sequence as the therapeutic antibody labetuzumab

Specifications

Detects human CEACAM5

Species Reactivity

Human

Target

CEACAM5

Applications

Functional Assays

Purification Method

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Concentration

5mg/mL

Endotoxin

<1EU/mg Determined by LAL gel clotting assay

Purity

≥95% monomer by analytical SEC, >95% by SDS Page

Buffer

ICH3002

Shipping Conditions

Blue ice

Storage Conditions

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Formulation

Sterile, preservative-free, solution in PBS. BSA and Azide free.

Applications Notes

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

More Discoveries

Explore Other Products

Browse additional items from our catalog

STX7 Antibody
A35925-50UL 50 μL

STX7 Antibody

Sign In for Pricing
View Details
Compound Fr12906
MF-0007416-01 100 mg

Compound Fr12906

Sign In for Pricing
View Details
Compound Fr12906
MF-0007416-02 2 mg

Compound Fr12906

Sign In for Pricing
View Details
Compound Fr12906
MF-0007416-03 10 mg

Compound Fr12906

Sign In for Pricing
View Details
SMPD2, NT (SMPD2, Sphingomyelin phosphodiesterase 2, Lyso-platelet-activating factor-phospholipase C, Neutral sphingomyelinase) (MaxLight 490) discontinued
042055-ML490 100 µL

SMPD2, NT (SMPD2, Sphingomyelin phosphodiesterase 2, Lyso-platelet-activating factor-phospholipase C, Neutral sphingomyelinase) (MaxLight 490) discontinued

Sign In for Pricing
View Details
INO80C Recombinant Protein Antigen
NBP2-14123PEP 0.1 mL

INO80C Recombinant Protein Antigen

Sign In for Pricing
View Details